▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Edwards Lifesciences (NYSE: EW)

$76.66

(0.5%)

$0.35

Price as of October 2, 2025, 3:58 p.m. ET

Edwards Lifesciences Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
EW	+17.22%	-3.17%	-0.64%	+5,450%
S&P	+17.56%	+100.43%	+14.92%	+340%

Edwards Lifesciences Company Info

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

News & Analysis

The Fool has written over 200 articles on Edwards Lifesciences.

Featured Article

Congressional Stock Trading: Who Trades and Makes the Most

Members of Congress have beaten the market in recent years but their trades have come under growing scrutiny

Jack Caporal | Jul 30, 2025

Featured Article

Best Medical Device Stocks to Buy for 2025

Keith Speights | Jul 29, 2025

These Are Billionaires’ Favorite Healthcare Stocks

Jack Caporal | May 15, 2024

The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.

Why Edwards Lifesciences Stock Plummeted Today

Eric Volkman | Oct 26, 2023

Investors trade on potential rather than trailing results, and they found the company's top-line guidance wanting.

3 No-Brainer Medical Device Stocks to Buy Right Now

James Halley | Apr 6, 2023

These companies have consistently delivered revenue and EPS gains.

Why Edwards Lifesciences Stock Crashed 16% Today

Rich Smith | Oct 28, 2022

Did investors overreact to the company's miss?

3 Unstoppable Investments Everyone Needs in Their Portfolio

James Brumley | Dec 31, 2021

There are still some names out there that can thrive in any environment.

Edwards Lifesciences Blows Past Q2 Earnings Estimates

Keith Speights | Jul 24, 2020

But the coronavirus pandemic continues to create uncertainty for the medical device maker.

Valuation

Podcast Episodes

Heart-Thumping, Game-Changing Ways We're Treating Cardiovascular Disease

In this Valentine's Day edition, Industry Focus explores cholesterol busters, heart surgery, and the latest in anticoagulants.

Todd Campbell and Kristine Harjes | Feb 22, 2017

Earnings Transcripts

Edwards Lifesciences (EW) Q2 2025 Earnings Call Transcript

None

Motley Fool Transcribing | Aug 5, 2025

Edwards Lifesciences (EW) Q2 2022 Earnings Call Transcript

EW earnings call for the period ending June 30, 2022.

Motley Fool Transcribing | Jul 29, 2022

Edwards Lifesciences (EW) Q1 2022 Earnings Call Transcript

EW earnings call for the period ending March 31, 2022.

Motley Fool Transcribing | Apr 27, 2022

Edwards Lifesciences (EW) Q4 2021 Earnings Call Transcript

EW earnings call for the period ending December 31, 2021.

Motley Fool Transcribing | Jan 27, 2022

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services